The relationship between human cytomegalovirus infection and atherosclerosis development

Molecular and Cellular Biochemistry

Volumn 249, Issue 1-2, 2003, Pages 91-96

  Chen, Ruizhen ^a,b   Xiong, Sidong ^a   Yang, Yingzhen ^a   Fu, Weiguo ^b   Wang, Yuqi ^b   Ge, Junbo ^a  

^a BEIJING HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Atherosclerosis (AS); ELISA; Human cytomegalovirus (HCMV); in situ hybridization; PCR

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE IDENTIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; VASCULAR TISSUE;

ANTIBODIES, VIRAL; CORONARY ARTERIOSCLEROSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GENES, IMMEDIATE-EARLY; GENES, VIRAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS LATENCY;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0042976446     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024759311013     Document Type: Article

References (14)

1. Castelli W: Epidemiology of coronary artery disease. Am J Med 76: 4-12, 1984
2. Martinez A, Castro A, Gil C et al.: Recent strategies in the development of new human cytomegalovirus inhibitors. Med Res Rev 21: 227-244, 2001
3. Fish KN, Stenglein SG, Ibanez C, Nelson JA: Cytomegalovirus persistence in macrophages and endothelial cells. Scand J Infect Dis 99(suppl): 34-40, 1995
4. Sommerschild HT: Is infection a pathogenetic factor in coronary heart disease? Ugeskr Laeger 163: 1834-1842, 2001
5. White SJ, Nicklin SA, Sawamura T, Baker AH: Identification of peptides that target the endothelial cell-specific LOX-1 receptor. Hypertension 37: 449-455, 2001
6. Legrand A, Mayar EP, Dalvi SS, Nachtigal M: Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region I. Am J Pathol 151: 1387-1395, 1997
7. Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE: Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 98: 2129-2138, 1996
8. Hendrix MG, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and non-atherosclerotic patients. Am J Pathol 134: 1151-1157, 1989
9. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ: Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71: 1554-1560, 2000
10. Castillo JP, Yurochko AD, Kowalik T: Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74: 8028-8037, 2000
11. Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE: Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis 156: 23-28, 2001
12. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261: 3561-3566, 1989
13. Tanaka K, Zoo JP, Takeda K, Ferrans VJ, Sandford GR, Johnson TM, Finkel T, Epstein SE: Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 99: 1656-1659, 1999
14. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE: Potential role of human cytomegalovirus and P53 interaction in coronary restenosis. Science 265: 391-394, 1994